메뉴 건너뛰기




Volumn 10, Issue 2, 2009, Pages 171-176

The changes of aggregability of blood platelets in schizophrenia

Author keywords

Aggregation; Antipsychotic drug; Blood platelet; Schizophrenia

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOZAPINE; COLLAGEN; HALOPERIDOL; OLANZAPINE; RISPERIDONE; NEUROLEPTIC AGENT;

EID: 67650115826     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701557993     Document Type: Article
Times cited : (24)

References (41)
  • 1
    • 0024488322 scopus 로고
    • Schizophrenia: A life-shortening illness
    • Allebeck P. 1989. Schizophrenia: A life-shortening illness. Schi-zophr Bull 15:81-89.
    • (1989) Schi-zophr Bull , vol.15 , pp. 81-89
    • Allebeck, P.1
  • 2
    • 0038207693 scopus 로고    scopus 로고
    • 2 A receptor density but not second messenger inositol triphoshate levels in drug-free schizophrenic patients
    • Arranz B, Rosel P, Sarro S, et al. 2003. Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol triphoshate levels in drug-free schizophrenic patients. Psychiatry Res 118:165-174.
    • (2003) Psychiatry Res , vol.118 , pp. 165-174
    • Arranz, B.1    Rosel, P.2    Sarro, S.3
  • 3
    • 33750520528 scopus 로고    scopus 로고
    • Glycerophospholipid molecular species in platelets and brain tissues-are platelets a good model for neurons?
    • Bakken AM, Staeffler A, Jorgensen HA, Holmsen H. 2006. Glycerophospholipid molecular species in platelets and brain tissues-are platelets a good model for neurons? Platelets 17:484-492
    • (2006) Platelets , vol.17 , pp. 484-492
    • Bakken, A.M.1    Staeffler, A.2    Jorgensen, H.A.3    Holmsen, H.4
  • 4
    • 0033056855 scopus 로고    scopus 로고
    • Super-sensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia
    • Berk M, Plein H, Czismadia T. 1999. Super-sensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. Int Clin Psychopharmaced 14:119-122.
    • (1999) Int Clin Psychopharmaced , vol.14 , pp. 119-122
    • Berk, M.1    Plein, H.2    Czismadia, T.3
  • 5
    • 0034640382 scopus 로고    scopus 로고
    • The specificy of platelet glutamate receptor supersensitivity in psychotic disorders
    • Berk M, Plein H, Belsham B. 2000. The specificy of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sci 66:2427-2432.
    • (2000) Life Sci , vol.66 , pp. 2427-2432
    • Berk, M.1    Plein, H.2    Belsham, B.3
  • 7
    • 0018423531 scopus 로고
    • Inhibition of 5-HAT uptake into neurons and platelets in mice treated chronically with chlorimipramide and femoxetine
    • Buus Lassen J, Lund J, Bechgaard E, Søndergaard I. 1979. Inhibition of 5-HAT uptake into neurons and platelets in mice treated chronically with chlorimipramide and femoxetine. Psychopharmacology 64:149-153.
    • (1979) Psychopharmacology , vol.64 , pp. 149-153
    • Buus Lassen, J.1    Lund, J.2    Bechgaard, E.3    Søndergaard, I.4
  • 8
    • 0031954102 scopus 로고    scopus 로고
    • Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects
    • Das I, Khan NS. 1998. Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects. Prostaglandins Leukot Essent Fatty Acids 58:165-168.
    • (1998) Prostaglandins Leukot Essent Fatty Acids , vol.58 , pp. 165-168
    • Das, I.1    Khan, N.S.2
  • 9
    • 6344276723 scopus 로고    scopus 로고
    • In vitro effects of risperidone and 9-hydroxyrisperidone on human platelet function, plasma coagulation, and fibrynolysis
    • De Clerck F, Somers Y, Mannaert E, et al. 2004. In vitro effects of risperidone and 9-hydroxyrisperidone on human platelet function, plasma coagulation, and fibrynolysis. Clin Ther 26:1261-1273.
    • (2004) Clin Ther , vol.26 , pp. 1261-1273
    • De Clerck, F.1    Somers, Y.2    Mannaert, E.3
  • 10
    • 0023522273 scopus 로고
    • Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophrenic form or schizophrenic disorders
    • Deminisch L, Gerbaldo H, Gebhart P, Greenspan A, Eerdekens M. 1987. Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophrenic form or schizophrenic disorders. Psychiatry Res 22:275-282.
    • (1987) Psychiatry Res , vol.22 , pp. 275-282
    • Deminisch, L.1    Gerbaldo, H.2    Gebhart, P.3    Greenspan, A.4    Eerdekens, M.5
  • 11
    • 61649102890 scopus 로고    scopus 로고
    • Soprostanes as indicators of oxidative stress in schizophrenia
    • Dietrich-Muszalska A, Olas B. 2007. soprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychiatry 10: 27-33.
    • (2007) World J Biol Psychiatry , vol.10 , pp. 27-33
    • Dietrich-Muszalska, A.1    Olas, B.2
  • 12
    • 27644584486 scopus 로고    scopus 로고
    • Oxidative stress in blood platelets from schizophrenic patients
    • Dietrich-Muszalska A, Olas B, Rabe-Jablonska J. 2005. Oxidative stress in blood platelets from schizophrenic patients. Platelets 16:386-391.
    • (2005) Platelets , vol.16 , pp. 386-391
    • Dietrich-Muszalska, A.1    Olas, B.2    Rabe-Jablonska, J.3
  • 13
    • 61649122462 scopus 로고    scopus 로고
    • Wplyw dzialania olanzapiny (Zolafren) na peroksydacje lipidow w ludzkich plytkach krwi i osoczu w ukladzie in vitro
    • Dietrich-Muszalska A, Rabe-Jablonska J, Zgirski A. 2004. Wplyw dzialania olanzapiny (Zolafren) na peroksydacje lipidow w ludzkich plytkach krwi i osoczu w ukladzie in vitro. Psychiatr Psychol Klin 4:13-19.
    • (2004) Psychiatr Psychol Klin , vol.4 , pp. 13-19
    • Dietrich-Muszalska, A.1    Rabe-Jablonska, J.2    Zgirski, A.3
  • 14
    • 3142545995 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
    • Eerdekens M, Hove IV, Remmerie B, et al. 2004. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizoph Res 70:91-100.
    • (2004) Schizoph Res , vol.70 , pp. 91-100
    • Eerdekens, M.1    Hove, I.V.2    Remmerie, B.3
  • 15
    • 0026450974 scopus 로고
    • Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4- phosphate in human platelets
    • Frolich KW, Aarbakke GM, Holmsen H. 1992. Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4-phosphate in human platelets. Biochem Pharmacol 44: 2013-2020.
    • (1992) Biochem Pharmacol , vol.44 , pp. 2013-2020
    • Frolich, K.W.1    Aarbakke, G.M.2    Holmsen, H.3
  • 16
    • 0034715191 scopus 로고    scopus 로고
    • Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment
    • DOI 10.1016/S0165-1781(00)00191-8, PII S0165178100001918
    • Govitrapong P, Chgkupit J, Turakitwanakan W, et al. 2004. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment. Psychiatry Res 96:41-50. (Pubitemid 30687408)
    • (2000) Psychiatry Research , vol.96 , Issue.1 , pp. 41-50
    • Govitrapong, P.1    Chagkutip, J.2    Turakitwanakan, W.3    Srikiatkhachorn, A.4
  • 17
    • 0022253263 scopus 로고
    • Different effects of centrally acting drugs on rabbit platelet aggregation: With special reference to selective inhibitiory effects of antipsychotics and antidepressants
    • Ishigooka J, Shizu Y, Wakatabe H, Tanaka K, Miura S. 1985. Different effects of centrally acting drugs on rabbit platelet aggregation: with special reference to selective inhibitiory effects of antipsychotics and antidepressants. Biol Psychiatry 20:866-873.
    • (1985) Biol Psychiatry , vol.20 , pp. 866-873
    • Ishigooka, J.1    Shizu, Y.2    Wakatabe, H.3    Tanaka, K.4    Miura, S.5
  • 19
    • 0033562632 scopus 로고    scopus 로고
    • Chlorpromazine and human platelet glycerolipid metabolism: Precursor specificity and significance of drug-platelet interaction time
    • Laasvatn KO, Holmsen H. 1999. Chlorpromazine and human platelet glycerolipid metabolism: precursor specificity and significance of drug-platelet interaction time. Biochem Pharmacol 57:1113-1123.
    • (1999) Biochem Pharmacol , vol.57 , pp. 1113-1123
    • Laasvatn, K.O.1    Holmsen, H.2
  • 20
    • 26144449142 scopus 로고    scopus 로고
    • Monoaminergic influence on the visual evoked potentials (VEP)
    • Magos T. 1998. Monoaminergic influence on the visual evoked potentials (VEP). Rec Adv Hum Neurophysiol 1:455-465
    • (1998) Rec Adv Hum Neurophysiol , vol.1 , pp. 455-465
    • Magos, T.1
  • 21
    • 70450279331 scopus 로고    scopus 로고
    • Correlation between platelet monoamine oxidase activity and the strength of a visual illusion
    • Magos T. 2001. Correlation between platelet monoamine oxidase activity and the strength of a visual illusion. Vision Res 42: 31-35.
    • (2001) Vision Res , vol.42 , pp. 31-35
    • Magos, T.1
  • 22
    • 0016368108 scopus 로고
    • Monamine oxidase in man: Enzyme characteristics in platelets, plasma, and other human tissues
    • Murphy DL, Donnelly CH. 1974. Monamine oxidase in man: Enzyme characteristics in platelets, plasma, and other human tissues. Adv Biochem Psychopharmacol 12:71-85.
    • (1974) Adv Biochem Psychopharmacol , vol.12 , pp. 71-85
    • Murphy, D.L.1    Donnelly, C.H.2
  • 23
    • 0036344313 scopus 로고    scopus 로고
    • Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion
    • Nowak P, Wachowicz B. 2002. Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets 13:293-299.
    • (2002) Platelets , vol.13 , pp. 293-299
    • Nowak, P.1    Wachowicz, B.2
  • 25
    • 0034668175 scopus 로고    scopus 로고
    • The integrin alpha IIb/beta 3 in human platelet signal transduction
    • Chap H.
    • Payrastre B, Missy K, Trumel C, Bodin S, Plantavid M, Chap H. 2000. The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol 60:1069-1074.
    • (2000) Biochem Pharmacol , vol.60 , pp. 1069-1074
    • Payrastre, B.1    Missy, K.2    Trumel, C.3    Bodin, S.4    Plantavid, M.5
  • 26
    • 0035001754 scopus 로고    scopus 로고
    • The platelet as a peripheral marker in psychiatric illness
    • Plein H, Berk M. 2001. The platelet as a peripheral marker in psychiatric illness. Hum Psychopharmacol Clin Exp 16: 229-236.
    • (2001) Hum Psychopharmacol Clin Exp , vol.16 , pp. 229-236
    • Plein, H.1    Berk, M.2
  • 27
    • 33846640656 scopus 로고    scopus 로고
    • Blunted serotonergic responsivity in neurolrptic-näive patients at first-episode of schizophrenia
    • Reddy R, Keshavan M, Yao JK. 2007. Blunted serotonergic responsivity in neurolrptic-näive patients at first-episode of schizophrenia. Schizophr Res 90:8105.
    • (2007) Schizophr Res , vol.90 , pp. 8105
    • Reddy, R.1    Keshavan, M.2    Yao, J.K.3
  • 28
    • 0034669992 scopus 로고    scopus 로고
    • Molecular mechanisms of platelet exocytosis: Insights into the secrete life of thrombocytes
    • Reed GL, Fitzgerald ML, Polgar J. 2000. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. Blood 96:3334-3342.
    • (2000) Blood , vol.96 , pp. 3334-3342
    • Reed, G.L.1    Fitzgerald, M.L.2    Polgar, J.3
  • 29
    • 0034902812 scopus 로고    scopus 로고
    • The platelet release reaction: Granules, constituents, secretion and functions
    • Rendu F, Brohard-Bohn B. 2001. The platelet release reaction: granules, constituents, secretion and functions. Platelets 12:261-273.
    • (2001) Platelets , vol.12 , pp. 261-273
    • Rendu, F.1    Brohard-Bohn, B.2
  • 32
    • 0032421570 scopus 로고    scopus 로고
    • The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
    • Sheehan DV, Lecrubier Y, Sheehan KH, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22-33.
    • (1998) J Clin Psychiatry , vol.59 , pp. 22-33
    • Sheehan, D.V.1    Lecrubier, Y.2    Sheehan, K.H.3
  • 33
    • 0034082029 scopus 로고    scopus 로고
    • Abnormal levels of camp-dependent protein kinase regulatory subunits in platelets from schizophrenic patients
    • Tardito D, Tura GB, Bocchio L. 2000. Abnormal levels of camp-dependent protein kinase regulatory subunits in platelets from schizophrenic patients. Neuropsychopharmacology 23: 216-219.
    • (2000) Neuropsychopharmacology , vol.23 , pp. 216-219
    • Tardito, D.1    Tura, G.B.2    Bocchio, L.3
  • 35
    • 4344631943 scopus 로고    scopus 로고
    • Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: How strong is the evidence?
    • Von Kanel R. 2004. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand 110:163-177.
    • (2004) Acta Psychiatr Scand , vol.110 , pp. 163-177
    • Von Kanel, R.1
  • 36
    • 0036839123 scopus 로고    scopus 로고
    • IIIa in drug-näive, first-episode schizophrenic patients
    • Walsh MT, Ryan M, Hillmann A, et al. 2002. Elevated expression of integrin aIIbbIIIa in drug-näive, first-episode schizophrenic patients. Biol Psychiatry 52:874-879.
    • (2002) Biol Psychiatry , vol.52 , pp. 874-879
    • Walsh, M.T.1    Ryan, M.2    Hillmann, A.3
  • 37
    • 0034730185 scopus 로고    scopus 로고
    • Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs
    • Yang J, Wu J, Kowalska MA, et al. 2000. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 97:9984-9999.
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 9984-9999
    • Yang, J.1    Wu, J.2    Kowalska, M.A.3
  • 38
    • 0028080258 scopus 로고
    • Platelet aggregation and dense granule secretion in schizophrenia
    • Yao JK, van Kammen DP, Gurklis J, Peters JL. 1994. Platelet aggregation and dense granule secretion in schizophrenia. Psychiatry Res 54:13-24.
    • (1994) Psychiatry Res , vol.54 , pp. 13-24
    • Yao, J.K.1    Van Kammen, D.P.2    Gurklis, J.3    Peters, J.L.4
  • 39
    • 0029658390 scopus 로고    scopus 로고
    • Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia
    • Yao JK, van Kammen DP. 1996. Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:21-26.
    • (1996) Prostaglandins Leukot Essent Fatty Acids , vol.55 , pp. 21-26
    • Yao, J.K.1    Van Kammen, D.P.2
  • 41
    • 0034619072 scopus 로고    scopus 로고
    • Antipsychotic drug and risk of first-time idiopathic venous thromboembolism: A case-control study
    • Zornberg GL, Jick H. 2000. Antipsychotic drug and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 356:1219-1223.
    • (2000) Lancet , vol.356 , pp. 1219-1223
    • Zornberg, G.L.1    Jick, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.